DOPATREE
Preview
Open in TheBrain
DOPATREE
EMA PHARMACOVIGILANCE ACTIVITIES
EMA PHARMACOVIGILANCE ACTIVITIES / LISTINGS / ADDITIONAL
CLINICAL STUDIES-ALL (CLINICAL TRIALS, STUDY, PROTOCOLS, MASTER PROTOCOLS, CLINICAL OPERATIONS, CLINICAL STUDY DESIGNS, COVARIATES, CONTINUOUS OUTCOMES, ICH E8, ENRICHMENT, STUDY REPORT, HOLD, CLINICAL INVESTIGATIONS)
CLINICAL STUDIES / TYPES
CLINICAL PHARMACOLOGY STUDIES (CP STUDIES, STUDY, HUMAN PHARMACOLOGY, DATA STUDIES)
CLINICAL PHARMACOLOGY STUDIES / TYPES
SPECIAL POPULATION STUDIES
SPECIAL POPULATION STUDIES / TYPES
DIFFERENT ETHNIC ORIGIN STUDIES
Parents
SPECIAL POPULATION STUDIES / TYPES
Children
ICH. EFFICACY GUIDELINES. ACCESSED : JUN 13, 2022. (E1-CLINICAL SAFETY FOR DRUGS USED IN LONG-TERM TREATMENT, E2-PHARMACOVIGILANCE, E3-CLINICAL STUDY REPORTS, E4-DOSE-RESPONSE STUDIES, E5-ETHNIC FACTORS, E6-GOOD CLINICAL PRACTICE, E7-CLINICAL TRIALS IN GERIATRIC POPULATION, E8-GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, E9-STATISTICAL PRINCIPLES FOR CLINICAL TRIALS, E10-CHOICE OF CONTROL GROUP IN CLINICAL TRIALS, E11-CLINICAL TRIALS IN PEDIATRIC POPULATION, E12-CLINICAL EVALUATION BY THERAPEUTIC CATEGORY (ANTIHYPERTENSIVE), E14-CLINICAL EVALUATION OF QT, E15-DEFINITIONS IN PHARMACOGENETICS AND PHARMACOGENOMICS, E16-QUALIFICATION OF GENOMIC BIOMARKERS, E17-MULTI-REGIONAL CLINICAL TRIALS, E18-GENOMIC SAMPLING, E19-SAFETY DATA COLLECTION, E20 ADAPTIVE CLINICAL TRIALS)